Sort
16,179 grants matching “malaria”
A modular platform for infectious disease surveillance at point-of-need.
$983,642Jay Kenneth Fisher · Redbud Labs, Inc. · R44 · FY2023 · AI
Attenuated Sporozoite Malaria Vaccine
$983,532Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2011 · AI
The BLOODSAFE Data Coordinating Center: A Data Center for More SafeTransfusions in Sub-Saharan Africa
$983,351Cavan S. Reilly · University Of Minnesota · U24 · FY2021 · HL
India International Center for Excellence in Research
$982,538Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Novel Plasmodial Surface Anion Channel Inhibitors as Antimalarial Drugs
$982,478Michelle M. Butler · Microbiotix, Inc · R44 · FY2021 · AI
PreQuine Platform. A novel point of care device for the diagnosis andmonitoring of Glucose-6-Phosphate Dehydrogenase (G6PD)
$982,381Robert Harper · Analytical Diagnostic Solutions, Inc. · SB1 · FY2023 · AI
CARIBBEAN PRIMATE RESEARCH CENTER PROGRAM
$982,256Edmundo Nelson Kraiselburd · University Of Puerto Rico Med Sciences · P40 · FY2007 · RR
Immune Deficient Mosquitoes for Improved Malaria Sporozoite Vaccine Manufacture
$981,741Peter F. Billingsley · Sanaria, Inc. · R44 · FY2018 · AI
India International Center for Excellence in Research
$981,020Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Cryopreservation of Anopheles Embryos
$980,922Peter F. Billingsley · Sanaria, Inc. · R44 · FY2015 · AI
Host Immune Responses to Antigens of Malaria Parasites
$980,178Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$979,886David S Stephens · Emory University · UM1 · FY2020 · AI
PfSPZ Vaccines: Quality Systems, Manufacturing, Regulatory, and Clinical Quality and Data Management Support for Product Commercialization
$978,475Stephen Lev Hoffman · Sanaria, Inc. · SB1 · FY2017 · AI
Identification of Gene Polymorphisms Associated with Infectious Diseases
$978,326Cheryl Winkler · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Marketing Strategic Plan and Distribution Logistics for Sanaria PfSPZ Vaccine against Malaria.
$977,597Stephen Lev Hoffman · Sanaria, Inc. · SB1 · FY2019 · AI
Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites
$977,419Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2021 · AI
International Clinical Trials Unit
$976,501John A Bartlett · Duke University · U01 · FY2006 · AI
Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine
$975,965John Adams · University Of South Florida · U01 · FY2022 · AI
Automating mosquito microdissection for a malaria PfSPZ vaccine
$975,729Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2019 · AI
Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine
$975,499John Adams · University Of South Florida · U01 · FY2023 · AI
PANDAA for universal, pan-lineage molecular detection of Crimean-Congo Hemorrhagic Fever virus.
$975,023Iain James Macleod · Aldatu Biosciences, Inc. · R44 · FY2025 · AI
Belmont Forum Collaborative Research: Decision making in the built environment as a public health intervention for malaria control
$974,572Esther Obonyo · Pennsylvania State Univ University Park · · FY2025 · GEO
Molecular Biomarkers for Malaria
$974,388Dyann F Wirth · Harvard School Of Public Health · R56 · FY2009 · AI
PfSPZ Vaccine for Malaria: Towards a Successful Biologics License Application and Commercialization
$974,007Stephen Lev Hoffman · Sanaria, Inc. · SB1 · FY2022 · AI
Cluster randomized trial of intermittent preventive treatment of malaria in school-agechildren to improve the health of students and decrease community transmission(CRITICal)
$973,555Matthew G Dorsey · University Of California, San Francisco · U01 · FY2025 · AI